How Post-Approval GMP Challenges Cooled Novo Nordisk’s Blazing Wegovy Launch
Executive Summary
Unrelated US FDA inspection led contract manufacturer to stop filling Wegovy syringes before alternate manufacturing facilities became available.
You may also be interested in...
Novo Nordisk Enjoys Obesity Sales Boost Despite Wegovy Supply Issues
Novo Nordisk’s obesity product sales have soared against the odds as supply chain issues for recently approved Wegovy continued.
Keeping Track: US FDA Approval Binge Includes Brexafemme, Wegovy, Ryplazim, Truseltiq, Lybalvi, Tembexa
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Defense Secretary Asked To Brief US Congress On Pharmaceutical Supply Chain Security
Congress seeks advice from Defense Department on procuring active pharmaceutical ingredients domestically for national security purposes as efforts to identify areas of concern get underway.